Froedtert/Medical College of Wisconsin
Milwaukee, Wisconsin 53226
11 studies enrolling now · 34 studies all time
What they study most
AML, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Advanced Cancer, Alzheimer's Disease, B-Cell Non-Hodgkin Lymphoma, B-cell Non Hodgkin Lymphoma, Bladder Cancer, Bone Marrow Disease, Breast Cancer, Bronchial Neuroendocrine Tumor, Carcinoid Syndrome
Studies at this site
- Phase 2 Study to Assess the Safety and Efficacy of ANG003 — Recruiting now
- A Study of ARC-02 in B-cell NHL — Recruiting now
- Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML — Recruiting now
- A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation — Recruiting now
- Study to Enable New Diagnostics for Pulmonary Microbes in People With CF — Recruiting now
- Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors — Recruiting now
- A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) — Recruiting now
- Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center — Recruiting now
- Pulmonary Hypertension Association Registry — Recruiting now
- Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials — Recruiting now
- EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment — Recruiting now
- A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7) — Running, not enrolling
- A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies — Completed
- COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies — Completed
- Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma — Completed
- Prospective Study of Pregnancy in Women With Cystic Fibrosis — Running, not enrolling
- CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) — Running, not enrolling
- Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer — Completed
- A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH) — Completed
- Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy — Completed
- Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study — Completed
- Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study — Completed
- Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease — Running, not enrolling
- Observational Study Comparing Home to Office Spirometry — Completed
- Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer — Completed
- Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma — Stopped early
- Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2 — Withdrawn before enrolling
- An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome — Completed
- Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma — Completed
- Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer — Completed
- Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial — Completed
- G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2) — Completed
- Avoiding Health Disparities When Collecting Patient Contextual Data for Clinical Care and Pragmatic Research — Completed
- Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors — Completed